Skip to main content
Jeanne Palmer, MD, Oncology, Phoenix, AZ, Mayo Clinic Hospital

JeanneMariePalmerMD

Oncology Phoenix, AZ

Hematologic Oncology

Consultant, Mayo Clinic

Dr. Palmer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Palmer's full profile

Already have an account?

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Hematology and Medical Oncology, 2005 - 2008
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2001 - 2004
  • New York Medical College
    New York Medical CollegeClass of 2001

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 2013 - 2024
  • WI State Medical License
    WI State Medical License 2008 - 2013
  • NY State Medical License
    NY State Medical License 2003 - 2005

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • A Phase II of Combination Daunorubicin and Cytarabine (Ara-c) and Nilotinib (TAsigna) (DATA) in Patients Newly Diagnosed with Acute Myeloid Leukemia and KIT Expression... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • CTI BioPharma Presents New Anemia Benefit Data from Pacritinib Program at the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition
    CTI BioPharma Presents New Anemia Benefit Data from Pacritinib Program at the 2022 American Society of Hematology (ASH) Annual Meeting and ExpositionDecember 11th, 2022
  • Pacritinib Approved for Intermediate- or High-Risk Myelofibrosis with Thrombocytopenia
    Pacritinib Approved for Intermediate- or High-Risk Myelofibrosis with ThrombocytopeniaMarch 3rd, 2022
  • Fighting Leukemia Then Joining the Team
    Fighting Leukemia Then Joining the TeamAugust 2nd, 2019
  • Join now to see all

Hospital Affiliations